Follicular lymphoma, unspecified
ICD-10 C82.9 is a billable code used to indicate a diagnosis of follicular lymphoma, unspecified.
Follicular lymphoma is a type of non-Hodgkin lymphoma that arises from B-lymphocytes, characterized by the proliferation of follicle center (germinal center) cells. It is typically indolent, meaning it progresses slowly, and is often diagnosed in advanced stages. The unspecified designation indicates that there is no further detail provided regarding the specific characteristics or subtype of the lymphoma. Patients may present with lymphadenopathy, splenomegaly, or asymptomatic disease. B-symptoms, which include fever, night sweats, and weight loss, may also be present, indicating a more aggressive disease course. Staging of follicular lymphoma is crucial for determining prognosis and treatment options, typically following the Ann Arbor staging system. Treatment may include watchful waiting for asymptomatic patients, chemotherapy, immunotherapy, or targeted therapies, depending on the stage and symptoms. The prognosis varies significantly based on the stage at diagnosis and the presence of B-symptoms, with early-stage disease generally having a better outcome than advanced-stage disease.
Detailed clinical notes including staging, treatment plans, and follow-up assessments.
Diagnosis of follicular lymphoma, management of treatment side effects, and monitoring for disease progression.
Accurate documentation of B-symptoms and treatment response is critical for coding and billing.
Histopathological reports confirming the diagnosis and subtype of lymphoma.
Biopsy interpretation and staging of lymphomas.
Pathology reports must clearly indicate the type of lymphoma to support accurate coding.
Used for patients receiving chemotherapy for follicular lymphoma.
Document the specific chemotherapy regimen and patient response.
Oncology specialists must ensure accurate coding of chemotherapy administration.
Common symptoms include painless swelling of lymph nodes, fever, night sweats, weight loss, and fatigue. Some patients may be asymptomatic.
